Candel therapeutics to present at the jefferies global healthcare conference

Needham, mass., may 22, 2024 (globe newswire) -- candel therapeutics, inc. (candel or the company) (nasdaq: cadl), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that paul peter tak, md, phd, fmedsci, candel's president and chief executive officer, will present a company overview at the jefferies global healthcare conference on wednesday, june 5, 2024 at 5:30 p.m. et.
CADL Ratings Summary
CADL Quant Ranking